Out-of-pocket costs to users: medicine options for hypertension.
Arredondo
Armando
A
Department for Health System Research, National Institute of Public Health, Cuernavaca, Morelos, México. aarredon@insp.mx
D000959:Antihypertensive Agents / Q000191:economics* / Q000627:therapeutic use; D003363:Cost Control; D017047:Cost Sharing; D003362:Cost-Benefit Analysis; D004338:Drug Combinations; D016527:Drug Costs; D011307:Drug Prescriptions; D004359:Drug Therapy, Combination; D016568:Drugs, Generic / Q000191:economics* / Q000627:therapeutic use; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D007356:Insurance, Pharmaceutical Services / Q000191:economics*; D010818:Practice Patterns, Physicians'; D011306:Prescription Fees
D000959:Antihypertensive Agents; D004338:Drug Combinations; D016568:Drugs, Generic